News on Guidant Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Guidant Corporation news from BioPortfolio.com Wed, 10 Feb 2010 16:08:10 GMT en A Good Day for J&J: Boston Scientific To Pay More in Stent Litigationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3992082&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3992082&THISHREF=http://c.moreover.com/click/here.pl%3fz2513987247%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3992082&HITNO=0&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3992082&THISHREF=http://c.moreover.com/click/here.pl%3fz2513987247%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWall Street Journal Online: Cardica Adds Brian E. Farley as Strategic Advisor - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941877&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941877&THISHREF=http://c.moreover.com/click/here.pl%3fz2485612620%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3941877&HITNO=1&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3941877&THISHREF=http://c.moreover.com/click/here.pl%3fz2485612620%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Whistleblower suit alleges off-label promotion of stentshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943800&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943800&THISHREF=http://c.moreover.com/click/here.pl%3fz2486270631%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943800&HITNO=2&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943800&THISHREF=http://c.moreover.com/click/here.pl%3fz2486270631%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCardiovascular Business: BSD Medical Names Todd Turnlund as Vice President of Engineeringhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931097&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931097&THISHREF=http://c.moreover.com/click/here.pl%3fz2480359372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931097&HITNO=3&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931097&THISHREF=http://c.moreover.com/click/here.pl%3fz2480359372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Lawsuit challenges biliary stent makershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3916969&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3916969&THISHREF=http://c.moreover.com/click/here.pl%3fz2472105580%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3916969&HITNO=4&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3916969&THISHREF=http://c.moreover.com/click/here.pl%3fz2472105580%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Biliary stent makers face lawsuit over marketing practiceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3916427&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3916427&THISHREF=http://c.moreover.com/click/here.pl%3fz2471875555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3916427&HITNO=5&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3916427&THISHREF=http://c.moreover.com/click/here.pl%3fz2471875555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Research and Markets: Global Cardiac Rhythm Management (CRM) Market 2008-2012http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905805&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905805&THISHREF=http://c.moreover.com/click/here.pl%3fz2466480729%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905805&HITNO=6&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905805&THISHREF=http://c.moreover.com/click/here.pl%3fz2466480729%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Research and Markets: Global Cardiac Rhythm Management (CRM) Market 2008-2012http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3902965&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3902965&THISHREF=http://c.moreover.com/click/here.pl%3fz2464967362%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3902965&HITNO=7&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3902965&THISHREF=http://c.moreover.com/click/here.pl%3fz2464967362%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Boston Sci, Abbott DES gain Japanese approvalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898877&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898877&THISHREF=http://c.moreover.com/click/here.pl%3fz2463045889%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898877&HITNO=8&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898877&THISHREF=http://c.moreover.com/click/here.pl%3fz2463045889%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCardiovascular Business: Boston Sci, Abbott DES gain Japanese approvalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3891052&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3891052&THISHREF=http://c.moreover.com/click/here.pl%3fz2459510258%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3891052&HITNO=9&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3891052&THISHREF=http://c.moreover.com/click/here.pl%3fz2459510258%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthImaging: Everolimus-Eluting Stents Gain Japanese Clearancehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880471&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880471&THISHREF=http://c.moreover.com/click/here.pl%3fz2453394103%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3880471&HITNO=10&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3880471&THISHREF=http://c.moreover.com/click/here.pl%3fz2453394103%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDiagnostic & Invasive Cardiology: Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent Systemhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3879544&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3879544&THISHREF=http://c.moreover.com/click/here.pl%3fz2452912878%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3879544&HITNO=11&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3879544&THISHREF=http://c.moreover.com/click/here.pl%3fz2452912878%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKLFY: UPDATE:Abbott Gets Approval To Market Popular Stent In Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878136&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878136&THISHREF=http://c.moreover.com/click/here.pl%3fz2452181682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878136&HITNO=12&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878136&THISHREF=http://c.moreover.com/click/here.pl%3fz2452181682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: UPDATE:Abbott Gets Approval To Market Popular Stent In Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878073&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878073&THISHREF=http://c.moreover.com/click/here.pl%3fz2452152555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3878073&HITNO=13&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3878073&THISHREF=http://c.moreover.com/click/here.pl%3fz2452152555%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCNN Money: UPDATE:Abbott Gets Approval To Market Popular Stent In Japanhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877853&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877853&THISHREF=http://c.moreover.com/click/here.pl%3fz2452079518%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3877853&HITNO=14&MSIZE=19&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Guidant%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3877853&THISHREF=http://c.moreover.com/click/here.pl%3fz2452079518%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNasdaq: